Thyroid neoplasm

Orphan designation: Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide, (L)-malate salt (cabozantinib) Treatment of medullary thyroid carcinoma, 06/02/2009 Positive

Retrieved on: 
Wednesday, April 3, 2024
Community, Eurostat, Civil service commission, Thyroid cancer, Diagnosis, Metabolism, Diarrhea, Enzyme, Hormone, Growth, Thyroid hormones, Prevalence, Cell, Calcitonin, Disease, Patient, Malignancy, Committee, Knowledge, Tissue, Seriousness, Doxorubicin, Boulogne-Billancourt, Regulation, Cancer, EMA, IRIS, Thyroid neoplasm, Cabozantinib, Protein, Medullary thyroid cancer, Thyroid, European, COMP, Iodine, European Commission, Safety, Blood, Marketing, Human, Pharmaceutical industry

Orphan designation: Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide, (L)-malate salt (cabozantinib) Treatment of medullary thyroid carcinoma, 06/02/2009 Positive

Key Points: 


Orphan designation: Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide, (L)-malate salt (cabozantinib) Treatment of medullary thyroid carcinoma, 06/02/2009 Positive

Exelixis Announces Breakthrough Therapy Designation Granted to Cabozantinib for the Treatment of Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Retrieved on: 
Thursday, February 25, 2021
Oncology, Health, FDA, General Health, Clinical trials, Pharmaceutical, Biotechnology, Anatomy, Thyroid disease, Organ systems, Glands, Thyroid cancer, Follicular thyroid cancer, Cabozantinib, Thyroid neoplasm, Thyroid nodule, Thyroid, Ipsen, Papillary thyroid cancer, COSMIC-311, Differentiated Thyroid Cancer, CABOMETYX® (cabozantinib)

In 2016, Exelixis granted Ipsen exclusive rights for the commercialization and further clinical development of cabozantinib outside of the United States and Japan.

Key Points: 
  • In 2016, Exelixis granted Ipsen exclusive rights for the commercialization and further clinical development of cabozantinib outside of the United States and Japan.
  • The incidence of Grade 3 to 5 hemorrhagic events was 5% in CABOMETYX patients in RCC and HCC studies.
  • Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer.
  • Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

Thyroid Eye Disease Treatments Market Research Report by Drug, by Route of Administration, by Treatment, by Diagnosis, by Distribution - Global Forecast to 2025 - Cumulative Impact of COVID-19

Retrieved on: 
Wednesday, July 29, 2020
Thyroid disease, Organ systems, Human anatomy, RTT, Endocrine system, Glands, Thyroid, Thyroid neoplasm, Graves' disease

Based on Treatment, the Thyroid Eye Disease Treatments Market studied across Medication, Radioactive Iodine Therapy, and Surgery.

Key Points: 
  • Based on Treatment, the Thyroid Eye Disease Treatments Market studied across Medication, Radioactive Iodine Therapy, and Surgery.
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Thyroid Eye Disease Treatments Market during the forecast period?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Thyroid Eye Disease Treatments Market?
  • What are the modes and strategic moves considered suitable for entering the Global Thyroid Eye Disease Treatments Market?

Veracyte Launches “More About You” Campaign to Educate Patients About Thyroid Cancer Diagnosis

Retrieved on: 
Friday, May 1, 2020
Biotechnology, Surgery, Health, Genetics, Oncology, Thyroid disease, Glands, Organ systems, Endocrine system, RTT, Endocrine diseases, Thyroid, Thyroid nodule, Thyroid cancer, Idiopathic pulmonary fibrosis, Computed tomography of the thyroid, Thyroid neoplasm, Thyroid Nodules, Afirma, Veracyte

The campaign centers on the companys new website, www.AskForAfirma.com , and addresses critical challenges that patients with potentially cancerous thyroid nodules experience during their diagnostic journey.

Key Points: 
  • The campaign centers on the companys new website, www.AskForAfirma.com , and addresses critical challenges that patients with potentially cancerous thyroid nodules experience during their diagnostic journey.
  • It also provides questions for patients to ask their physicians once a thyroid nodule has been detected.
  • Veracyte will communicate information about the campaign and website to patients and physicians via online, social media and other channels.
  • Since its founding in 2008, Veracyte has commercialized seven genomic tests and is transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis.

The Global Thyroid Eye Disease Treatment Market is expected to grow from USD 211.49 Million in 2019 to USD 344.19 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.45%

Retrieved on: 
Monday, April 13, 2020
Glands, Thyroid disease, Human anatomy, Organ systems, Thyroid, RTT, Endocrine system, Pharmacy, Hyperthyroidism, Thyroid neoplasm

On the basis of Treatment, the Thyroid Eye Disease Treatment Market is studied across Medication, Radioactive Iodine Therapy, and Surgery.

Key Points: 
  • On the basis of Treatment, the Thyroid Eye Disease Treatment Market is studied across Medication, Radioactive Iodine Therapy, and Surgery.
  • On the basis of Distribution, the Thyroid Eye Disease Treatment Market is studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • On the basis of Geography, the Thyroid Eye Disease Treatment Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.
  • What are the modes and strategic moves considered suitable for entering the Global Thyroid Eye Disease Treatment Market?

Interpace Biosciences Announces Another Pricing improvement for its Thyroid Assay

Retrieved on: 
Tuesday, February 11, 2020
Glands, Organ systems, Endocrine system, Thyroid cancer, Thyroid disease, Medullary thyroid cancer, Follicular thyroid cancer, Thyroid neoplasm, Thyroid

According to Jack Stover, CEO of Interpace, We are pleased with the thorough assessment given by CMS in evaluating one of our key products with the result of improved pricing for ThyraMIR.

Key Points: 
  • According to Jack Stover, CEO of Interpace, We are pleased with the thorough assessment given by CMS in evaluating one of our key products with the result of improved pricing for ThyraMIR.
  • We believe this modification represents value-based pricing and reflects the critical impact ThyraMIR has on identifying a surgical need from surveillance.
  • ThyGeNEXT utilizes state-of-the-art next-generation sequencing (NGS) to identify more than 100 genetic alterations associated with papillary and follicular thyroid carcinomas, the two most common forms of thyroid cancer, as well as Medullary Thyroid Carcinoma.
  • Interpace Pharma Solutions Is a business unit of Interpace Biosciences that provides pharmacogenomics testing, genotyping, biorepository and other customized services to the pharmaceutical and biotech industries.

85% of People Do Not Know How to Perform a Life-Saving Thyroid Check, New Paloma Health Survey Finds

Retrieved on: 
Tuesday, January 14, 2020
Thyroid disease, Organ systems, Human anatomy, Thyroid, Endocrine system, Glands, Endocrine diseases, Thyroid neoplasm, Thyroid disease in women

SANTA BARBARA, Calif., Jan. 14, 2020 /PRNewswire/ --Despite thyroid disease prevalence, most people do not perform thyroid self-checks1.

Key Points: 
  • SANTA BARBARA, Calif., Jan. 14, 2020 /PRNewswire/ --Despite thyroid disease prevalence, most people do not perform thyroid self-checks1.
  • The thyroid is a butterfly-shaped gland at the base of your neck.
  • If the thyroid produces too much, or too little hormones, it can create problems with fatigue, mood, weight, fertility, and most critical systems.
  • A thyroid hub where women can learn more about thyroid disorders, download thyroid guides, and learn how to do an at-home self-exam.

85% of People Do Not Know How to Perform a Life-Saving Thyroid Check, New Paloma Health Survey Finds

Retrieved on: 
Tuesday, January 14, 2020
Thyroid disease, Organ systems, Human anatomy, Thyroid, Endocrine system, Glands, Endocrine diseases, Thyroid neoplasm, Thyroid disease in women

SANTA BARBARA, Calif., Jan. 14, 2020 /PRNewswire/ --Despite thyroid disease prevalence, most people do not perform thyroid self-checks1.

Key Points: 
  • SANTA BARBARA, Calif., Jan. 14, 2020 /PRNewswire/ --Despite thyroid disease prevalence, most people do not perform thyroid self-checks1.
  • The thyroid is a butterfly-shaped gland at the base of your neck.
  • If the thyroid produces too much, or too little hormones, it can create problems with fatigue, mood, weight, fertility, and most critical systems.
  • A thyroid hub where women can learn more about thyroid disorders, download thyroid guides, and learn how to do an at-home self-exam.

Interpace Biosciences Announces New Draft LCD and Reimbursement for Its Proprietary Thyroid Assay, ThyGeNEXT®

Retrieved on: 
Tuesday, December 17, 2019
Thyroid disease, Glands, Organ systems, Endocrine system, Thyroid cancer, Thyroid neoplasm, Thyroid, Follicular thyroid cancer, Medullary thyroid cancer, Papillary thyroid cancer, Computed tomography of the thyroid

This increase in reimbursement rates reflects the expansion of the ThyGeNEXT panel to aid in identifying the appropriate patients for surgery.

Key Points: 
  • This increase in reimbursement rates reflects the expansion of the ThyGeNEXT panel to aid in identifying the appropriate patients for surgery.
  • ThyGeNEXT has been covered by an existing LCD since it was launched in mid-2018 and its predecessor, ThyGenX, has been covered since 2014.
  • ThyGeNEXT utilizes state-of-the-art next-generation sequencing (NGS) to identify more than 100 genetic alterations associated with papillary and follicular thyroid carcinomas, the two most common forms of thyroid cancer, as well as Medullary Thyroid Carcinoma.
  • ThyGeNEXT and ThyraMIR reflex testing yields high predictive value in determining the presence and absence of cancer in thyroid nodules.

Global Thyroid Cancer Drugs Market Report 2020: Focus on Ipilimumab, Cabozantinib-S-Malate, Caprelsa, Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 11, 2019
Pharmaceutical, Health, Oncology, Glands, Human anatomy, RTT, Endocrine system, Thyroid disease, Thyroid, Thyroid cancer, Cancer, Thyroid neoplasm, Wolff–Chaikoff effect

The thyroid cancer drugs market consists of sales of drugs that are used to treat thyroid cancer.

Key Points: 
  • The thyroid cancer drugs market consists of sales of drugs that are used to treat thyroid cancer.
  • North America was the largest region in the thyroid cancer drugs market in 2018, followed by Europe.
  • Increasing incidences of thyroid cancer, especially in women is driving the thyroid cancer drugs market.
  • Increasing use of targeted therapies for the treatment of thyroid cancer is acting as a restraint on the thyroid cancer drugs market.